🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My great friend and colleague Stefano Aliberti giving the keynote lecture here is Glasgow on inflammation in bronchiectasis

Beautiful Merete Long from James D Chalmers lab doing lucky draw for British Association for Lung Research (BALR) come and join us and try your luck!

Looking very happy to be presenting data on long term antibiotic use in the EMBARC cohort #rti2025

Brilliant Rebecca Hull from James D Chalmers lab with an important topic of resistant bacteria infection in bronchiectasis! Lena Group Respiratory Hub 🫁 #RTI2025

Fantastic whizz through Azithromycin and all its different properties including the ability to manipulate your patients asthma phenotype Timothy Hinks #RTI2025

Brilliant work Brian Massive for patients with CRSNP

Congratulations Dr Chloe Hughes! Viva passed! Fantastic work on cardiovascular ❤️ risk and inflammation in Covid19 Celebration for the respiratory research group 🎉🎉🎉🎉🎉🎉 Thanks for external examiner Prof Lynne Prince UoD Medicine University of Dundee

New EMBARC registry data published ThoraxBMJ - study from 31 countries Inhaled corticosteroids are used by 52.3% of bronchiectasis patients Outcomes are generally worse among ICS users which may be confounding by indication Eosinophilic patients have lower exacerbations!

We did it! Absolutely thrilled to share the results of the ASPEN trial published today in NEJM Brensocatib(10mg and 25mg vs placebo) reduced exacerbations over 52 weeks and slowed lung function decline A new treatment for bronchiectasis patients nej.md/4lBHwUr

When science delivers, we celebrate! Congrats to the researchers, patients, and the bronchiectasis community on this milestone. Brensocatib is officially in the spotlight! #Bronchiectasis #Brensocatib #NEJM #LungHealth #ClinicalTrials #PulmonaryMedicine #RespiratoryHealth

Thanks so much to Stuart Elborn, Daniel Morales and Samira Bell for a really great viva experience. And huge thanks to James D Chalmers Amelia Shoemark and the amazing respiratory research group in Dundee for the best, most memorable 3 years doing this PhD.

Dr Merete Long - American Thoracic Society (ATS) rising star award winner 2025 for her contributions to bronchiectasis and respiratory infection research Congratulations to an outstanding scientist and colleague Never a more deserving winner 👏👏👏👏❤️❤️❤️❤️ UoD Medicine ATS PI-TB Assembly Merete Long

On international clinical trials day we say thank you to all of the patients participating in bronchiectasis research to find new treatments and understand more about the disease #bronchiectasis EMBARC Stefano Aliberti Merete Long Holly Lind Dr. Kateryna Viligorska European Lung Foundation

Thrilled to announce exciting results of the Great2 trial of a monoclonal antibody against Pseudomonas in bronchiectasis - reduce bacterial load at day 84 - significant improvement in quality of life - reduced exacerbations Merete Long EMBARC bronchiectasis.net/clinical-trial…

An opportunity for people with bronchiectasis (and their carers) to ask questions and get excellent, evidence-based advice from international experts Join us for #worldbronchiectasisday

The new European Respiratory Journal impact factor is 21. Ranked #2 across all resp journals Thank you to the incredible Don Sin , all authors, our outstanding editors and journal staff ♥️ ERS publications ERS IF for selected respiratory journals below

Join international experts in bronchiectasis to learn more about the latest guidance and research at our World Bronchiectasis Day Webinar register here: europeanlung.org/en/get-involve… Here Amelia Shoemark talks about the importance of research

James D Chalmers Merete Long European Lung Foundation ERS GREAT work Prof

The new ERS Handbook is incoming! Edited by Paolo Palange and Anita Simonds, with Associate Editors Stefano Aliberti, Najib M. Rahman and Christian Karagiannidis it brings together a worldwide group of expert authors...(1/2)

New in ERS publications Merete Long from University of Dundee discussing interesting new data on IL-33 in COPD from FRONTIER-4 IL-33 is a promising anti-inflammatory mechanism, and awaiting results of large replicate randomized trials publications.ersnet.org/content/erj/66…